CDNA CareDx, Inc Stock Quote

CDNA [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-0.35	Insider Own	1.40%	Shs Outstand	52.68M	Perf Week	4.00%
Market Cap	2.08B	Forward P/E	100.55	EPS next Y	0.38	Insider Trans	-10.02%	Shs Float	51.77M	Perf Month	-12.42%
Income	-18.00M	PEG	-	EPS next Q	0.03	Inst Own	-	Short Float	6.17%	Perf Quarter	-45.25%
Sales	275.80M	P/S	7.55	EPS this Y	22.70%	Inst Trans	-0.17%	Short Ratio	3.83	Perf Half Y	-54.18%
Book/sh	8.96	P/B	4.30	EPS next Y	11.01%	ROA	-3.60%	Target Price	99.33	Perf Year	-49.61%
Cash/sh	6.72	P/C	5.73	EPS next 5Y	20.00%	ROE	-4.20%	52W Range	35.18 - 96.88	Perf YTD	-15.33%
Dividend	-	P/FCF	-	EPS past 5Y	19.00%	ROI	-6.00%	52W High	-60.25%	Beta	0.67
Dividend %	-	Quick Ratio	6.10	Sales past 5Y	46.80%	Gross Margin	67.60%	52W Low	9.47%	ATR	2.94
Employees	456	Current Ratio	6.40	Sales Q/Q	41.60%	Oper. Margin	-6.30%	RSI (14)	43.73	Volatility	8.49% 7.65%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-292.70%	Profit Margin	-6.50%	Rel Volume	0.49	Prev Close	36.85
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Oct 28 AMC	Payout	-	Avg Volume	834.30K	Price	38.51
Recom	1.70	SMA20	-6.42%	SMA50	-9.52%	SMA200	-42.09%	Volume	404,907	Change	4.50%

Jul-20-21

Resumed

BTIG Research

Buy

$115

Jun-03-21

Initiated

Goldman

Buy

$95

Feb-26-21

Downgrade

H.C. Wainwright

Buy → Neutral

Oct-30-20

Reiterated

H.C. Wainwright

Buy

$47 → $55

Oct-08-20

Reiterated

H.C. Wainwright

Buy

$45 → $47

Oct-02-20

Reiterated

H.C. Wainwright

Buy

$40 → $45

Aug-05-20

Reiterated

H.C. Wainwright

Buy

$37 → $40

Jun-26-20

Initiated

BTIG Research

Buy

$40

Jun-19-20

Reiterated

H.C. Wainwright

Buy

$40 → $37

Oct-01-19

Resumed

Craig Hallum

Buy

$48

May-09-19

Upgrade

H.C. Wainwright

Neutral → Buy

$30 → $43

Feb-15-19

Initiated

Jefferies

Buy

$35

Oct-23-18

Resumed

Raymond James

Strong Buy

$30

Sep-18-18

Reiterated

H.C. Wainwright

Neutral

$17 → $22

Nov-27-17

Initiated

H.C. Wainwright

Buy

$12

Jun-14-16

Reiterated

Mizuho

Buy

$12 → $8

Sep-29-15

Downgrade

Raymond James

Outperform → Mkt Perform

Sep-25-15

Initiated

Craig Hallum

Buy

Mar-18-15

Reiterated

Mizuho

Buy

$15 → $12

Jan-27-22 01:38PM	Zweig-DiMenna Associates LLC Buys Caterpillar Inc, Macy's Inc, Teck Resources, Sells PayPal ... GuruFocus.com
Jan-25-22 10:53AM	Is CareDx (CDNA) Still a Worthy Investment Choice? Insider Monkey
Jan-20-22 07:00AM	CareDx Joins Forces with MOTTEP to Increase Organ Donations for Minority Transplant Patients and Support High-Risk, Underserved Communities GlobeNewswire
Jan-19-22 05:38PM	Searle & Co. Buys The Chemours Co, Wells Fargo, HireRight Holdings Corp, Sells CareDx Inc, ... GuruFocus.com
Jan-14-22 09:38AM	Mesirow Financial Investment Management, Inc. ... GuruFocus.com
Jan-12-22 07:00AM	Landmark ADMIRAL Study Publication with CareDxs AlloSure Kidney is the First Long-Term Multicenter Prospective Clinical Validation for Routine Organ Transplant Surveillance GlobeNewswire -5.36%
Jan-11-22 07:00AM	CareDx Partners with Multiple Biotechnology Companies to Use AlloCell in CAR T-Cell Therapy Clinical Studies GlobeNewswire
Jan-10-22 07:00AM	CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2021 GlobeNewswire +18.48%
Jan-07-22 07:00AM	NIH Study Shows Using CareDxs AlloSure Lung for Transplant Surveillance is More Effective than Diagnostic Bronchoscopy at Identifying Rejection GlobeNewswire
Jan-06-22 07:00AM	CareDx Successfully Completes CLIA Validation of AlloMap Kidney in Preparation for Commercial Launch GlobeNewswire
Jan-05-22 07:00AM	CareDx Expands Its Medication Adherence Services with the Acquisition of The Transplant Pharmacy GlobeNewswire -11.01%
Jan-04-22 07:00AM	CareDx Partners with ISHLT in a Transplant Innovation Research Grant to Improve Outcomes for Heart and Lung Transplant Patients GlobeNewswire
Dec-31-21 07:45PM	Ongoing Investigation Notice: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm NewMediaWire
07:00PM	ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
06:34PM	CareDx Shareholder Notice NewMediaWire
Dec-30-21 05:51PM	CareDx Shareholder Alert NewMediaWire
Dec-29-21 05:51PM	CareDx Investor Alert NewMediaWire
Dec-27-21 06:01PM	CareDx Investor Alert NewMediaWire
Dec-26-21 08:27AM	CareDx Shareholder Alert NewMediaWire
Dec-24-21 06:34PM	CareDx Investor Alert NewMediaWire
Dec-22-21 06:14PM	CareDx Shareholder Notice NewMediaWire
Dec-21-21 06:12PM	CareDx Shareholder Alert NewMediaWire
Dec-20-21 06:02PM	CareDx Investor Alert NewMediaWire
Dec-19-21 04:36PM	ROSEN, A TOP RANKED LAW FIRM, Encourages CareDx, Inc. Investors with Losses to Inquire About Securities Class Action Investigation - CDNA PR Newswire
04:00PM	10 Artificial Intelligence Stocks in Cathie Woods Portfolio Insider Monkey
08:27AM	Action Alert: CareDx Shareholder NewMediaWire
Dec-18-21 02:38AM	Putnam Funds Trust Buys Definitive Healthcare Corp, F45 Training Holdings Inc, RBC Bearings ... GuruFocus.com
Dec-17-21 06:34PM	CareDx Investor Alert NewMediaWire +7.11%
Dec-16-21 06:49PM	Lost Money in CareDx, Inc.? Business Wire -5.13%
07:00AM	CareDx Enrolls First Patient in LungCare Registry Study to Measure Impact of Multimodality Assessment on Lung Transplant Patient Outcomes GlobeNewswire
Dec-13-21 07:00AM	CareDx Partners with the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Organization in Launching Prospective, Multi-Center Pediatric Kidney Transplant Study GlobeNewswire
Dec-12-21 09:00PM	CAREDX ALERT: Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. on Behalf of CareDx Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Dec-10-21 12:30PM	Hedge Funds Are Getting More Bullish On CareDx, Inc. (CDNA) Insider Monkey
Dec-07-21 09:00PM	CAREDX ALERT: Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. on Behalf of CareDx Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
03:59PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firms Attorneys, Firm Investigating Possible Securities Law Violations GlobeNewswire
02:33PM	Cathie Woods ARK Portfolio: Top 15 Losers Insider Monkey
02:03PM	ROSEN, RESPECTED INVESTOR COUNSEL, Encourages CareDx, Inc. Investors to Inquire About Securities Class Action Investigation - CDNA PR Newswire
Dec-03-21 08:06PM	ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm Newsfile
06:34PM	CareDx Investor Alert Newsfile
Dec-02-21 09:00PM	CAREDX ALERT: Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. on Behalf of CareDx Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
06:38PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firms Attorneys, Firm Investigating Possible Securities Law Violations GlobeNewswire
06:33PM	CareDx Update Newsfile
10:00AM	ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
07:00AM	CareDx The Transplant Company Surpasses 80,000 Patient Milestone GlobeNewswire
Dec-01-21 06:32PM	Insider Buying Could Indicate a Bottom in These 2 Strong Buy Stocks TipRanks
06:32PM	CareDx Shareholder Notice Newsfile
09:11AM	Acushnet Holdings, CareDx, Lululemon and Chewy highlighted as Zacks Bull and Bear of the Day Zacks
07:09AM	Bear Of The Day:CareDX Zacks
Nov-30-21 06:23PM	CareDx Shareholder Alert Newsfile
10:05AM	INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Nov-29-21 06:02PM	CareDx Investor Alert Newsfile
06:57AM	3 Unstoppable Growth Stocks You Can Buy for Less Than $100 Right Now Motley Fool
Nov-28-21 08:22AM	CareDx Shareholder Alert Newsfile
Nov-27-21 05:00AM	CAREDX ALERT: Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. on Behalf of CareDx Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Nov-26-21 06:24PM	CareDx Investor Alert Newsfile
10:12AM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations Newsfile
Nov-25-21 06:18PM	CareDx Update Newsfile
Nov-24-21 07:33PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates CareDx, Inc. PR Newswire +5.21%
06:12PM	CareDx Shareholder Notice Newsfile
Nov-23-21 08:07PM	INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm PR Newswire
04:42PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firms Attorneys, Firm Investigating Possible Securities Law Violations GlobeNewswire
05:26AM	Even though CareDx (NASDAQ:CDNA) has lost US$306m market cap in last 7 days, shareholders are still up 999% over 5 years Simply Wall St.
Nov-22-21 02:29PM	INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against CareDx, Inc and Encourages Investors With Losses to Contact the Firm Newsfile
11:34AM	CAREDX INVESTIGATION: Block & Leviton Is Investigating CareDx, Inc. For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm GlobeNewswire
10:00AM	INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Nov-21-21 08:22AM	CareDx Shareholder Alert Newsfile
Nov-19-21 06:21PM	CareDx Shareholder Alert Newsfile
10:30AM	ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
07:00AM	CareDx Named One of the Fastest-Growing Companies in North America on the Deloitte Technology Fast 500 for the Third Consecutive Year GlobeNewswire
Nov-18-21 06:19PM	CareDx Shareholder Alert Newsfile
02:00PM	CDNA ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating CareDx, Inc. (NASDAQ:CDNA) for Potential Securities Violations ACCESSWIRE
11:49AM	Baron Funds on CareDx (CDNA): We are not Concerned by the Short-Term Dip in the Share Price Insider Monkey
10:15AM	ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
09:36AM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firms Attorneys Now, Firm Investigating Possible Securities Law Violations ACCESSWIRE
07:00AM	CareDx Enrolls First Patients in the Largest Digital Study in Transplant Using AlloCare to Assess Patient Outcomes GlobeNewswire
Nov-17-21 10:00PM	CAREDX ALERT: Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. on Behalf of CareDx Stockholders and Encourages Investors to Contact the Firm Business Wire -8.36%
02:52PM	ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm Newsfile
11:30AM	CDNA ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating CareDx, Inc. (NASDAQ:CDNA) for Potential Securities Violations ACCESSWIRE
10:00AM	INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Nov-16-21 06:12PM	CareDx Shareholder Alert Newsfile
01:51PM	CDNA INVESTIGATION: Hagens Berman Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations Newsfile
01:15PM	CDNA Investor Alert: Thornton Law Firm Continues Investigation Newsfile
09:50AM	INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Nov-15-21 08:00PM	CDNA ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating CareDx, Inc. (NASDAQ:CDNA) for Potential Securities Violations ACCESSWIRE
06:04PM	CareDx Investor Alert Newsfile
05:29PM	HAGENS BERMAN Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firms Attorneys Now, Firm Investigating Possible Securities Law Violations GlobeNewswire
04:28PM	ROSEN, A TOP RANKED LAW FIRM, Encourages CareDx, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation CDNA GlobeNewswire
04:05PM	CareDx To Participate in Upcoming Conferences GlobeNewswire
03:34PM	IINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm Newsfile
12:07PM	CAREDX INVESTIGATION: Block & Leviton Is Investigating CareDx, Inc. For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm GlobeNewswire
01:00AM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Nov-14-21 09:39AM	CAREDX SHAREHOLDER ALERT Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In CareDx To Contact Him Directly To Discuss Their Options Newsfile
Nov-12-21 06:04PM	CareDx Shareholder Alert Newsfile
06:00PM	CDNA ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating CareDx, Inc. (NASDAQ:CDNA) for Potential Securities Violations ACCESSWIRE
04:06PM	INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of CareDx, Inc. (CDNA) Investors Business Wire
03:31PM	CDNA INVESTOR ALERT: Hagens Berman Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firms Attorneys Now, Firm Investigating Possible Securities Law Violations ACCESSWIRE
10:30AM	ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Nov-11-21 06:02PM	CareDx Shareholder Alert Newsfile
Nov-10-21 11:46AM	Director Of Caredx Trades $680K In Company Stock Benzinga
09:45AM	ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It offers AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; and AlloSure Heart, a dd-cfDNA test to identify underlying cell injury leading to organ rejection. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables precision; and TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Ottr, a transplant patient tracking software; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors. CareDx, Inc. has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize KidneyCare iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. It also has a collaborative research agreement with Eledon Pharmaceuticals, Inc. to use AlloSure for assessing the efficacy of Eledon's investigational AT-1501 in the prevention of rejection in upcoming renal transplantation trials. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in South San Francisco, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Seeto Reginald	See Remarks	Jan 19	Sale	40.05	3,137	125,634	132,560	Jan 19 04:49 PM
Seeto Reginald	See Remarks	Jan 18	Sale	40.07	1,719	68,881	135,697	Jan 19 04:49 PM
Goldberg Michael	Director	Jan 10	Option Exercise	1.22	500	610	61,767	Jan 11 05:52 PM
Goldberg Michael	Director	Jan 10	Sale	42.97	500	21,485	61,267	Jan 11 05:52 PM
Maag Peter	Director	Jan 05	Option Exercise	24.30	10,000	242,986	351,756	Jan 06 06:07 PM
Maag Peter	Director	Jan 05	Sale	44.45	10,000	444,466	341,756	Jan 06 06:07 PM
Goldberg Michael	Director	Dec 09	Option Exercise	1.22	500	610	61,068	Dec 13 06:30 PM
Goldberg Michael	Director	Dec 09	Sale	45.41	500	22,705	60,568	Dec 13 06:30 PM
Maag Peter	Director	Dec 06	Option Exercise	18.90	10,000	188,951	351,756	Dec 07 04:29 PM
Maag Peter	Director	Dec 06	Sale	41.62	10,000	416,190	341,756	Dec 07 04:29 PM
Dhingra Ankur	Chief Financial Officer	Nov 24	Buy	42.34	5,000	211,694	5,000	Nov 29 04:19 PM
Goldberg Michael	Director	Nov 09	Option Exercise	1.22	500	610	61,068	Nov 10 04:47 PM
Goldberg Michael	Director	Nov 09	Sale	47.54	500	23,770	60,568	Nov 10 04:47 PM
Maag Peter	Director	Nov 05	Option Exercise	18.90	10,000	188,969	351,756	Nov 09 06:01 PM
TORRES ARTHUR A	Director	Nov 05	Buy	47.62	600	28,572	2,855	Nov 09 05:47 PM
Maag Peter	Director	Nov 05	Sale	49.40	10,000	494,000	341,756	Nov 09 06:01 PM
Goldberg Michael	Director	Oct 11	Option Exercise	1.22	500	610	61,068	Oct 12 05:19 PM
Goldberg Michael	Director	Oct 11	Sale	62.50	500	31,251	60,568	Oct 12 05:19 PM
Maag Peter	Executive Chair	Oct 05	Option Exercise	18.17	10,000	181,661	351,756	Oct 06 07:40 PM
Maag Peter	Executive Chair	Oct 05	Sale	64.67	10,000	646,735	341,756	Oct 06 07:40 PM
Maag Peter	Executive Chair	Sep 07	Option Exercise	10.65	3,448	36,718	351,756	Sep 07 08:36 PM
Maag Peter	Executive Chair	Sep 07	Sale	73.68	10,000	736,763	341,756	Sep 07 08:36 PM
Seeto Reginald	See Remarks	Aug 27	Sale	80.00	658	52,642	142,534	Aug 27 04:43 PM
Seeto Reginald	See Remarks	Aug 11	Option Exercise	27.72	10,821	299,958	143,192	Aug 17 06:59 PM
Maag Peter	Executive Chair	Aug 05	Option Exercise	11.36	4,958	56,333	354,256	Aug 09 04:56 PM
Maag Peter	Executive Chair	Aug 05	Sale	83.13	10,000	831,313	349,298	Aug 09 04:56 PM
Seeto Reginald	See Remarks	Jul 08	Sale	85.67	5,994	513,503	132,634	Jul 09 07:28 PM
Maag Peter	Executive Chair	Jul 06	Option Exercise	12.24	2,312	28,299	374,256	Jul 07 06:31 PM
Maag Peter	Executive Chair	Jul 06	Sale	90.70	10,000	907,002	364,256	Jul 07 06:31 PM
Seeto Reginald	See Remarks	Jun 28	Option Exercise	26.84	13,212	354,613	145,583	Aug 17 06:59 PM
Seeto Reginald	See Remarks	Jun 28	Sale	95.75	13,212	1,264,990	132,371	Aug 17 06:59 PM
Maag Peter	Executive Chair	Jun 25	Option Exercise	24.35	395	9,618	372,339	Jun 25 07:54 PM
Seeto Reginald	See Remarks	Jun 25	Option Exercise	26.53	9,210	244,359	141,581	Aug 17 06:59 PM
Seeto Reginald	See Remarks	Jun 25	Sale	95.15	9,210	876,318	132,371	Aug 17 06:59 PM
Maag Peter	Executive Chair	Jun 25	Sale	95.00	395	37,525	371,944	Jun 25 07:54 PM
Maag Peter	Executive Chair	Jun 24	Option Exercise	23.76	9,605	228,217	381,549	Jun 25 07:54 PM
Maag Peter	Executive Chair	Jun 24	Sale	95.30	9,605	915,398	371,944	Jun 25 07:54 PM
Seeto Reginald	See Remarks	Jun 09	Option Exercise	26.56	16,718	444,066	159,352	Jun 11 05:51 PM
Maag Peter	Executive Chair	Jun 09	Option Exercise	24.35	2,522	61,411	374,466	Jun 11 05:52 PM
HAGSTROM WILLIAM A	Director	Jun 09	Option Exercise	4.95	5,000	24,750	23,575	Jun 11 05:52 PM
King Sasha	Chief Marketing Officer	Jun 09	Option Exercise	5.25	5,055	26,520	52,574	Jun 11 05:51 PM
King Sasha	Chief Marketing Officer	Jun 09	Sale	90.01	12,435	1,119,263	40,139	Jun 11 05:51 PM
HAGSTROM WILLIAM A	Director	Jun 09	Sale	88.14	5,000	440,706	18,575	Jun 11 05:52 PM
Maag Peter	Executive Chair	Jun 09	Sale	90.00	2,522	226,982	371,944	Jun 11 05:52 PM
Seeto Reginald	See Remarks	Jun 09	Sale	90.01	16,718	1,504,819	142,634	Jun 11 05:51 PM
Maag Peter	Executive Chair	Jun 08	Option Exercise	24.35	978	23,814	372,922	Jun 09 08:27 PM
King Sasha	Chief Marketing Officer	Jun 08	Option Exercise	16.04	1,000	16,037	48,519	Jun 09 08:30 PM
Seeto Reginald	See Remarks	Jun 08	Option Exercise	27.72	500	13,860	143,134	Jun 09 08:32 PM
Seeto Reginald	See Remarks	Jun 08	Sale	90.00	500	45,001	142,634	Jun 09 08:32 PM
King Sasha	Chief Marketing Officer	Jun 08	Sale	90.02	1,000	90,024	47,519	Jun 09 08:30 PM
Maag Peter	Executive Chair	Jun 08	Sale	90.05	978	88,074	371,944	Jun 09 08:27 PM
King Sasha	Chief Marketing Officer	Jun 07	Option Exercise	20.13	8,071	162,438	55,590	Jun 08 06:37 PM
Seeto Reginald	See Remarks	Jun 07	Option Exercise	27.72	9,973	276,452	152,607	Jun 08 06:39 PM
Maag Peter	Executive Chair	Jun 07	Option Exercise	19.37	7,592	147,021	398,444	Jun 08 06:41 PM
Maag Peter	Executive Chair	Jun 07	Sale	86.25	26,500	2,285,752	371,944	Jun 08 06:41 PM
Seeto Reginald	See Remarks	Jun 07	Sale	90.01	9,973	897,644	142,634	Jun 08 06:39 PM
King Sasha	Chief Marketing Officer	Jun 07	Sale	90.01	8,071	726,461	47,519	Jun 08 06:37 PM
SNYDERMAN RALPH	Director	Jun 02	Sale	81.57	2,511	204,815	51,015	Jun 10 05:32 PM
SNYDERMAN RALPH	Director	Jun 01	Sale	77.30	2,512	194,173	53,526	Jun 10 05:32 PM
SNYDERMAN RALPH	Director	May 28	Sale	81.08	2,511	203,595	56,038	Jun 10 05:32 PM
SNYDERMAN RALPH	Director	May 27	Sale	81.01	1,966	159,266	58,549	Jun 10 05:32 PM
Maag Peter	Executive Chair	May 25	Option Exercise	27.17	10,000	271,700	419,444	May 27 05:04 PM
Maag Peter	Executive Chair	May 25	Sale	80.59	10,000	805,871	409,444	May 27 05:04 PM
Bickerstaff George	Director	May 21	Sale	75.34	10,000	753,373	60,938	May 21 07:50 PM
HAGSTROM WILLIAM A	Director	May 14	Option Exercise	5.41	10,000	54,138	28,575	May 17 04:16 PM
HAGSTROM WILLIAM A	Director	May 14	Sale	66.89	10,000	668,884	18,575	May 17 04:16 PM
Bickerstaff George	Director	May 12	Sale	63.07	10,000	630,747	70,938	May 13 09:11 PM
Maag Peter	Executive Chair	May 11	Option Exercise	12.24	87,128	1,066,447	496,572	May 12 06:53 PM
Goldberg Michael	Director	May 11	Option Exercise	2.95	49,083	144,574	107,586	May 12 06:56 PM
Goldberg Michael	Director	May 11	Sale	66.60	49,083	3,268,972	58,503	May 12 06:56 PM
Maag Peter	Executive Chair	May 11	Sale	66.60	87,128	5,802,799	409,444	May 12 06:53 PM
Maag Peter	Executive Chair	May 10	Option Exercise	9.61	26,293	252,741	435,737	May 12 06:53 PM
Goldberg Michael	Director	May 10	Option Exercise	2.95	15,442	45,484	73,945	May 12 06:56 PM
Goldberg Michael	Director	May 10	Sale	68.94	15,442	1,064,561	58,503	May 12 06:56 PM
Maag Peter	Executive Chair	May 10	Sale	68.94	26,293	1,812,623	409,444	May 12 06:53 PM
Maag Peter	Executive Chair	May 05	Option Exercise	27.17	10,000	271,700	419,444	May 06 08:55 PM
Maag Peter	Executive Chair	May 05	Sale	73.32	10,000	733,192	409,444	May 06 08:55 PM
Maag Peter	Executive Chair	May 03	Option Exercise	19.87	15,086	299,778	428,054	May 04 06:55 PM
Maag Peter	Executive Chair	May 03	Sale	76.64	20,000	1,532,723	408,054	May 04 06:55 PM
Maag Peter	Executive Chair	Apr 05	Sale	72.40	10,000	724,015	412,968	Apr 06 04:29 PM
Maag Peter	Executive Chair	Mar 05	Sale	61.29	10,000	612,852	422,968	Mar 05 08:45 PM
Seeto Reginald	See Remarks	Mar 01	Sale	85.45	10,704	914,700	142,634	Mar 01 04:23 PM
Maag Peter	Executive Chair	Feb 05	Sale	89.82	10,000	898,190	412,800	Feb 05 07:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience